Rolf Barth to Antiviral Agents
This is a "connection" page, showing publications Rolf Barth has written about Antiviral Agents.
Connection Strength
0.120
-
Valganciclovir is an effective prophylaxis for cytomegalovirus disease in liver transplant recipients. HPB (Oxford). 2010 Dec; 12(10):657-63.
Score: 0.072
-
The Impact of Treatment Delay on Hepatitis C Liver Transplant Outcomes. J Pharm Pract. 2023 Apr; 36(2):264-270.
Score: 0.037
-
Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma. Cancer Res. 2003 Mar 01; 63(5):965-71.
Score: 0.010